Alcon Inc. (ALC) News
Filter ALC News Items
ALC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ALC News Highlights
- ALC's 30 day story count now stands at 10.
- Over the past 25 days, the trend for ALC's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about ALC are CDMO, LFCR and PRE.
Latest ALC News From Around the Web
Below are the latest news stories about ALCON INC that investors may wish to consider to help them evaluate ALC as an investment opportunity.
Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?Here is how Alcon (ALC) and Swedish Orphan Biovitrum (BIOVF) have performed compared to their sector so far this year. |
Alcon's (VTX:ALC) investors will be pleased with their 22% return over the last three yearsBy buying an index fund, investors can approximate the average market return. But if you buy good businesses at... |
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term CustomerNew $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loanCHASKA, Minn., May 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company” Nasdaq: LFCR), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has entered into a broad set of agreements with its long-term customer, Alcon (SIX/NYSE: ALC), which provides for the repayment of the Company’s |
Alcon Advances Company’s Social Impact Through Global VolunteerismGENEVA, May 22, 2023--Alcon Advances Company’s Social Impact Through Global Volunteerism |
Alcon (ALC) Vision Care Sales Robust, Margin Pressure PersistsFor Alcon (ALC), in terms of end market, Surgical global cataract procedure growth varies significantly by region. |
Alcon (ALC) Q1 Earnings Surpass Estimates, 23' EPS View UpAlcon (ALC) Q1 revenues were driven by strong consumables and equipment sales. |
4 big analyst picks: Alcon upgraded to Outperform after Q1 beat | Pro RecapBaird upgraded Alcon (NYSE:ALC) to Outperform from Neutral and raised its price target to $90.00 from $75.00 following Q1 earnings. Shares jumped more than 7% pre-market today after the company reported its Q1 results, with EPS of $0.70 and revenue of $2.3 billion beating the consensus estimates. BTIG upgraded NeoGenomics (NASDAQ:NEO) to Buy from Neutral with a price target of $25.00, noting it was impressed by the change in underlying growth at the company since the new management team has taken over. |
Alcon Reports First Quarter 2023 ResultsGENEVA, May 09, 2023--Alcon Reports First Quarter 2023 Results |
New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of VisionFORT WORTH, Texas, May 06, 2023--New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of Vision |
Alcon Announces Results of 2023 Annual General MeetingGENEVA, May 05, 2023--Alcon Announces Results of 2023 Annual General Meeting |